BridgeMD
New treatment option for Interstitial Lung Disease
Official title Ultrasound and Respiratory Physiological Signals in Lung Diseases
ClinicalTrials.gov ID: NCT06068647
What this study is testing
- What it's testing
- The use of lung ultrasound is instrumental in the evaluation of many chest pathologies and its ability to detect pleuro-pulmonary pathology is widely accepted. However, the use of ultrasound to explore the state of the peripheral lung parenchyma, when the organ is still aerated, is a relatively new application.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- inpatients admitted to the hospital due to diffuse interstitial lung diseases during exacerbation OR infectious interstitial pneumonia not caused by...
- Outpatients with pulmonary paraseptal and/or panlobular emphysema and/or chronic obstructive pulmonary disease during stable phase.
- Patients able to give written informed consent.
You likely can't join if
- history of skin irritation, redness, itching or allergic cutaneous symptoms.
- Allergic reactions to adhesives or hydrogels.
- Family history of adhesive skin allergies.
- Presence of severe skin conditions such as wounds, burns or on any damaged skin.
- Presence of strong magnetic fields in the study setting.
- Presence of electromagnetic disturbances or significant ionizing radiation sources which might lead to signal artifacts.
See the full eligibility criteria
- inpatients admitted to the hospital due to diffuse interstitial lung diseases during exacerbation OR infectious interstitial pneumonia not caused by SARS-CoV-2 OR acute exacerbation of chronic obstructive pulmonary...
- Outpatients with pulmonary paraseptal and/or panlobular emphysema and/or chronic obstructive pulmonary disease during stable phase.
- Patients able to give written informed consent.
- history of skin irritation, redness, itching or allergic cutaneous symptoms.
- Allergic reactions to adhesives or hydrogels.
- Family history of adhesive skin allergies.
- Presence of severe skin conditions such as wounds, burns or on any damaged skin.
- Presence of strong magnetic fields in the study setting.
- Presence of electromagnetic disturbances or significant ionizing radiation sources which might lead to signal artifacts.
- Use of external cardiac defibrillators.
- Use of diaphragmatic pacers.
- Use of extra cardiac stimulators.
- Pregnancy.
- Pediatric population.
The study team makes the final eligibility decision.
Where it's taking place
- Rome, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rome, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.